{"id":1628,"date":"2014-05-29T00:00:00","date_gmt":"2014-05-29T04:00:00","guid":{"rendered":"https:\/\/icesontario.wpengine.com\/journal-articles\/higher-potency-statins-and-the-risk-of-new-diabetes-multicentre-observational-study-of-administrative-databases\/"},"modified":"2023-06-14T20:00:48","modified_gmt":"2023-06-15T00:00:48","slug":"higher-potency-statins-and-the-risk-of-new-diabetes-multicentre-observational-study-of-administrative-databases","status":"publish","type":"journal_article","link":"https:\/\/www.ices.on.ca\/fr\/publications\/journal-articles\/higher-potency-statins-and-the-risk-of-new-diabetes-multicentre-observational-study-of-administrative-databases\/","title":{"rendered":"Higher potency statins and the risk of new diabetes: multicentre, observational study of administrative databases"},"content":{"rendered":"<p><strong>Objective<\/strong> &#x2014; To evaluate the incremental increase in new onset diabetes from higher potency statins compared with lower potency statins when used for secondary prevention. <\/p>\n<p><strong>Design <\/strong>&#x2014; Eight population based cohort studies and a meta-analysis.&#xa0;<\/p>\n<p><strong>Setting<\/strong> &#x2014; Six Canadian provinces and two international databases from the UK and US. <\/p>\n<p><strong>Participants<\/strong> &#x2014; 136 966 patients aged &#x2265;40 years newly treated with statins between 1 January 1997 and 31 March 2011. <\/p>\n<p><strong>Methods<\/strong> &#x2014; Within each cohort of patients newly prescribed a statin after hospitalisation for a major cardiovascular event or procedure,&#xa0;the researchers&#xa0;performed as-treated, nested case-control analyses to compare diabetes incidence in users of higher potency statins with incidence in users of lower potency statins. Rate ratios of new diabetes events were estimated using conditional logistic regression on different lengths of exposure to higher potency versus lower potency statins; adjustment for confounding was achieved using high dimensional propensity scores. Meta-analytic methods were used to estimate overall effects across sites. Main outcome measure Hospitalisation for new onset diabetes, or a prescription for insulin or an oral antidiabetic drug. <\/p>\n<p><strong>Results <\/strong>&#x2014; In the first two years of regular statin use, we observed a significant increase in the risk of new onset diabetes with higher potency statins compared with lower potency agents (rate ratio 1.15, 95% confidence interval 1.05 to 1.26). The risk increase seemed to be highest in the first four months of use (rate ratio 1.26, 1.07 to 1.47). <\/p>\n<p><strong>Conclusions<\/strong> &#x2014; Higher potency statin use is associated with a moderate increase in the risk of new onset diabetes compared with lower potency statins in patients treated for secondary prevention of cardiovascular disease. Clinicians should consider this risk when prescribing higher potency statins in secondary prevention patients. <\/p>\n","protected":false},"excerpt":{"rendered":"<p>Objective &#x2014; To evaluate the incremental increase in new onset diabetes from higher potency statins compared with lower potency statins when used for secondary prevention. Design &#x2014; Eight population based cohort studies and a meta-analysis.&#xa0; Setting &#x2014; Six Canadian provinces and two international databases from the UK and US. Participants &#x2014; 136 966 patients aged [&hellip;]<\/p>\n","protected":false},"template":"","migration-helper-automated":[],"migration-manual":[],"topic":[50,56],"migration-helper-qa-sample-set":[],"class_list":["post-1628","journal_article","type-journal_article","status-publish","hentry","topic-endocrinology","topic-pharmacoepidemiology-and-drug-safety"],"acf":{"citation":"Dormuth CR, Filion KB, Paterson JM, James MT, Teare GF, Raymond CB, Rahme E, Tamim H, Lipscombe L; CNODES Investigators. <em>BMJ.<\/em> 2014. 348:g3244.","source_url":"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4038449\/","ices_scientist":[1295],"site":[6735],"research_program":[6746],"news_release":[7338],"journal_article":[],"atlas":[],"research_report":[],"infographic":[],"video":[],"downloads":null,"links":null,"sitecore_item_id":"B99E4C36-04FD-44C7-BCBE-C14C05D25C68","sitecore_item_name":"Higher-potency-statins-and-the-risk-of-new-diabetes","sitecore_field_values":"{\n  \"__Never publish\": null,\n  \"__Valid from\": \"20170818T123513\",\n  \"Title\": \"Higher potency statins and the risk of new diabetes: multicentre, observational study of administrative databases\",\n  \"Short title\": \"Higher potency statins\",\n  \"Summary\": \"To evaluate the incremental increase in new onset diabetes from higher potency statins compared with lower potency statins when used for secondary prevention.\",\n  \"Citation\": \"<p>Dormuth CR, Filion KB, Paterson JM, James MT, Teare GF, Raymond CB, Rahme E, Tamim H, Lipscombe L; CNODES Investigators. <em>BMJ.<\/em> 2014. 348:g3244.<\/p>\",\n  \"Abstract\": \"<p><strong>Objective<\/strong> &mdash; To evaluate the incremental increase in new onset diabetes from higher potency statins compared with lower potency statins when used for secondary prevention. <\/p>n<p><strong>Design <\/strong>&mdash; Eight population based cohort studies and a meta-analysis.&nbsp;<\/p>n<p><strong>Setting<\/strong> &mdash; Six Canadian provinces and two international databases from the UK and US. <\/p>n<p><strong>Participants<\/strong> &mdash; 136 966 patients aged &ge;40 years newly treated with statins between 1 January 1997 and 31 March 2011. <\/p>n<p><strong>Methods<\/strong> &mdash; Within each cohort of patients newly prescribed a statin after hospitalisation for a major cardiovascular event or procedure,&nbsp;the researchers&nbsp;performed as-treated, nested case-control analyses to compare diabetes incidence in users of higher potency statins with incidence in users of lower potency statins. Rate ratios of new diabetes events were estimated using conditional logistic regression on different lengths of exposure to higher potency versus lower potency statins; adjustment for confounding was achieved using high dimensional propensity scores. Meta-analytic methods were used to estimate overall effects across sites. Main outcome measure Hospitalisation for new onset diabetes, or a prescription for insulin or an oral antidiabetic drug. <\/p>n<p><strong>Results <\/strong>&mdash; In the first two years of regular statin use, we observed a significant increase in the risk of new onset diabetes with higher potency statins compared with lower potency agents (rate ratio 1.15, 95% confidence interval 1.05 to 1.26). The risk increase seemed to be highest in the first four months of use (rate ratio 1.26, 1.07 to 1.47). <\/p>n<p><strong>Conclusions<\/strong> &mdash; Higher potency statin use is associated with a moderate increase in the risk of new onset diabetes compared with lower potency statins in patients treated for secondary prevention of cardiovascular disease. Clinicians should consider this risk when prescribing higher potency statins in secondary prevention patients. <\/p>n<p><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4038449\/\" title=\"opens external link\">View full text<\/a><\/p>\",\n  \"Keywords\": \"{26EB1DB1-6793-4CB3-9CFB-DFF37E09FB5A}|{119824F7-24C7-4BEC-A5CC-4699A1DB30E1}\",\n  \"Related Products\": \"<h2>News Release<\/h2>rn<h3><a href=\"~\/link.aspx?_id=F5C773534C66459B8600EAF2E362B10F&amp;_z=z\">High-potency statins linked to increased risk of diabetes<\/a><\/h3>rn<h2><a href=\"~\/link.aspx?_id=2F3FF37C088747AA987C04BA1C142AE9&amp;_z=z\">IN THE NEWS<\/a><\/h2>rn<h3><a href=\"http:\/\/www.ctvnews.ca\/health\/study-links-statins-to-higher-diabetes-risk-1.1843765\" title=\"Link to CTV\" target=\"_blank\">Study links statins to higher diabetes risk <\/a><\/h3>\",\n  \"Research Programs\": \"{668015E6-BBDE-450E-86B3-6831008D6E36}|{CFE36C89-C969-4C23-B5E4-1BA9E5BDC273}\",\n  \"ICES Locations\": \"{FBE2D1B1-C0BA-423F-8D16-39466B6C1424}\",\n  \"ICES Scientists\": \"{DC2C9ADE-ED70-4834-A8AC-A7271C6E48F5}\",\n  \"Posted Date\": \"20140529T113400\",\n  \"Show on Publications Landing Page\": \"1\"\n}","previous_url":"https:\/\/www.ices.on.ca\/Publications\/Journal-Articles\/2014\/January\/Higher-potency-statins-and-the-risk-of-new-diabetes"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ICES | Higher potency statins and the risk of new diabetes: multicentre, observational study of administrative databases<\/title>\n<meta name=\"description\" content=\"Objective &#x2014; To evaluate the incremental increase in new onset diabetes from higher potency statins compared with lower potency statins when used\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ices.on.ca\/fr\/publications\/journal-articles\/higher-potency-statins-and-the-risk-of-new-diabetes-multicentre-observational-study-of-administrative-databases\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ICES | Higher potency statins and the risk of new diabetes: multicentre, observational study of administrative databases\" \/>\n<meta property=\"og:description\" content=\"Objective &#x2014; To evaluate the incremental increase in new onset diabetes from higher potency statins compared with lower potency statins when used\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ices.on.ca\/fr\/publications\/journal-articles\/higher-potency-statins-and-the-risk-of-new-diabetes-multicentre-observational-study-of-administrative-databases\/\" \/>\n<meta property=\"og:site_name\" content=\"ICES\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ICESOntario\/\" \/>\n<meta property=\"article:modified_time\" content=\"2023-06-15T00:00:48+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.ices.on.ca\/wp-content\/uploads\/2024\/11\/ic-es-data-discovery-better-health-logo.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"675\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/publications\\\/journal-articles\\\/higher-potency-statins-and-the-risk-of-new-diabetes-multicentre-observational-study-of-administrative-databases\\\/\",\"url\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/publications\\\/journal-articles\\\/higher-potency-statins-and-the-risk-of-new-diabetes-multicentre-observational-study-of-administrative-databases\\\/\",\"name\":\"ICES | Higher potency statins and the risk of new diabetes: multicentre, observational study of administrative databases\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/#website\"},\"datePublished\":\"2014-05-29T04:00:00+00:00\",\"dateModified\":\"2023-06-15T00:00:48+00:00\",\"description\":\"Objective &#x2014; To evaluate the incremental increase in new onset diabetes from higher potency statins compared with lower potency statins when used\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/publications\\\/journal-articles\\\/higher-potency-statins-and-the-risk-of-new-diabetes-multicentre-observational-study-of-administrative-databases\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/publications\\\/journal-articles\\\/higher-potency-statins-and-the-risk-of-new-diabetes-multicentre-observational-study-of-administrative-databases\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/publications\\\/journal-articles\\\/higher-potency-statins-and-the-risk-of-new-diabetes-multicentre-observational-study-of-administrative-databases\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Journal Articles\",\"item\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/publications\\\/journal-articles\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Higher potency statins and the risk of new diabetes: multicentre, observational study of administrative databases\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/\",\"name\":\"ICES\",\"description\":\"POPULATION-BASED HEALTH RESEARCH THAT MAKES A DIFFERENCE\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/#organization\"},\"alternateName\":\"Institute for Clinical Evaluative Sciences\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/#organization\",\"name\":\"ICES\",\"alternateName\":\"Institute for Clinical Evaluative Sciences\",\"url\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.ices.on.ca\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/ices-logo.png\",\"contentUrl\":\"https:\\\/\\\/www.ices.on.ca\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/ices-logo.png\",\"width\":\"676\",\"height\":\"618\",\"caption\":\"ICES\"},\"image\":{\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/ICESOntario\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/ices-research-institute\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ICES | Higher potency statins and the risk of new diabetes: multicentre, observational study of administrative databases","description":"Objective &#x2014; To evaluate the incremental increase in new onset diabetes from higher potency statins compared with lower potency statins when used","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ices.on.ca\/fr\/publications\/journal-articles\/higher-potency-statins-and-the-risk-of-new-diabetes-multicentre-observational-study-of-administrative-databases\/","og_locale":"fr_FR","og_type":"article","og_title":"ICES | Higher potency statins and the risk of new diabetes: multicentre, observational study of administrative databases","og_description":"Objective &#x2014; To evaluate the incremental increase in new onset diabetes from higher potency statins compared with lower potency statins when used","og_url":"https:\/\/www.ices.on.ca\/fr\/publications\/journal-articles\/higher-potency-statins-and-the-risk-of-new-diabetes-multicentre-observational-study-of-administrative-databases\/","og_site_name":"ICES","article_publisher":"https:\/\/www.facebook.com\/ICESOntario\/","article_modified_time":"2023-06-15T00:00:48+00:00","og_image":[{"width":1200,"height":675,"url":"https:\/\/www.ices.on.ca\/wp-content\/uploads\/2024\/11\/ic-es-data-discovery-better-health-logo.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.ices.on.ca\/fr\/publications\/journal-articles\/higher-potency-statins-and-the-risk-of-new-diabetes-multicentre-observational-study-of-administrative-databases\/","url":"https:\/\/www.ices.on.ca\/fr\/publications\/journal-articles\/higher-potency-statins-and-the-risk-of-new-diabetes-multicentre-observational-study-of-administrative-databases\/","name":"ICES | Higher potency statins and the risk of new diabetes: multicentre, observational study of administrative databases","isPartOf":{"@id":"https:\/\/www.ices.on.ca\/fr\/#website"},"datePublished":"2014-05-29T04:00:00+00:00","dateModified":"2023-06-15T00:00:48+00:00","description":"Objective &#x2014; To evaluate the incremental increase in new onset diabetes from higher potency statins compared with lower potency statins when used","breadcrumb":{"@id":"https:\/\/www.ices.on.ca\/fr\/publications\/journal-articles\/higher-potency-statins-and-the-risk-of-new-diabetes-multicentre-observational-study-of-administrative-databases\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ices.on.ca\/fr\/publications\/journal-articles\/higher-potency-statins-and-the-risk-of-new-diabetes-multicentre-observational-study-of-administrative-databases\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.ices.on.ca\/fr\/publications\/journal-articles\/higher-potency-statins-and-the-risk-of-new-diabetes-multicentre-observational-study-of-administrative-databases\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.ices.on.ca\/fr\/"},{"@type":"ListItem","position":2,"name":"Journal Articles","item":"https:\/\/www.ices.on.ca\/fr\/publications\/journal-articles\/"},{"@type":"ListItem","position":3,"name":"Higher potency statins and the risk of new diabetes: multicentre, observational study of administrative databases"}]},{"@type":"WebSite","@id":"https:\/\/www.ices.on.ca\/fr\/#website","url":"https:\/\/www.ices.on.ca\/fr\/","name":"ICES","description":"POPULATION-BASED HEALTH RESEARCH THAT MAKES A DIFFERENCE","publisher":{"@id":"https:\/\/www.ices.on.ca\/fr\/#organization"},"alternateName":"Institute for Clinical Evaluative Sciences","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ices.on.ca\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.ices.on.ca\/fr\/#organization","name":"ICES","alternateName":"Institute for Clinical Evaluative Sciences","url":"https:\/\/www.ices.on.ca\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.ices.on.ca\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.ices.on.ca\/wp-content\/uploads\/2023\/04\/ices-logo.png","contentUrl":"https:\/\/www.ices.on.ca\/wp-content\/uploads\/2023\/04\/ices-logo.png","width":"676","height":"618","caption":"ICES"},"image":{"@id":"https:\/\/www.ices.on.ca\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ICESOntario\/","https:\/\/www.linkedin.com\/company\/ices-research-institute\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/journal_article\/1628","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/journal_article"}],"about":[{"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/types\/journal_article"}],"acf:post":[{"embeddable":true,"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/news_release\/7338"},{"embeddable":true,"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/research_program\/6746"},{"embeddable":true,"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/site\/6735"},{"embeddable":true,"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/ices_scientist\/1295"}],"wp:attachment":[{"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/media?parent=1628"}],"wp:term":[{"taxonomy":"migration-helper-automated","embeddable":true,"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/migration-helper-automated?post=1628"},{"taxonomy":"migration-manual","embeddable":true,"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/migration-manual?post=1628"},{"taxonomy":"topic","embeddable":true,"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/topic?post=1628"},{"taxonomy":"migration-helper-qa-sample-set","embeddable":true,"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/migration-helper-qa-sample-set?post=1628"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}